Localized in vivo 1H NMR spectroscopy of murine tumours: Effect of blood flow reduction

NMR in Biomedicine

Volumn 12, Issue 4, 1999, Pages 175-183

  Nielsen, F U ^a   Topp, S ^b   Horsman, M R ^c   Overgaard, J ^c   Stodkilde Jorgensen H ^a   Maxwell, R J ^a,d  

^a AARHUS UNIVERSITY   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; GLYCEROPHOSPHORYLCHOLINE; HYDRALAZINE; LACTIC ACID; PHOSPHORYLCHOLINE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPERATURE DEPENDENCE; TUMOR BLOOD FLOW; ANIMAL; BLOOD FLOW; C3H MOUSE; DRUG EFFECT; EXPERIMENTAL NEOPLASM; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TEMPERATURE; VASCULARIZATION;

ANIMALIA; MURINAE;

ANIMALS; CHOLINE; HYDRALAZINE; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; REGIONAL BLOOD FLOW; TEMPERATURE;

EID: 0032586985     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199906)12:4<175::AID-NBM552>3.0.CO;2-F     Document Type: Article

References (33)

1. Chaplin, D. J. and Acker, B. The effect of hydralazine on the tumour cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain Int. J. Radiat. Oncol. Biol. Phys. 13, 579-585 (1987).
2. Bremner, J. C. M., Stratford, I. J., Bowler, J. and Adams, G. E. Bioreductive drugs and the selective induction of tumour hypoxia. Br. J. Cancer 61, 717-721 (1990).
3. Horsman, M. R., Christensen, K. L. and Overgaard, J. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo. Int. J. Hyperthermia 5, 123-136 (1989).
4. Chaplin, D. J., Acker, B. and Olive, P. L. Potentiation of the tumour cytotoxity of melphalan by vasodilating drugs. Int. J. Radiat. Oncol. Biol. Phys. 16, 1131-1135 (1989).
5. Adams, G. E., Stratford, I. J., Godden, J. and Howells, N. Enhancement of the anti-tumour effect of melphalan in experimental mice by some vaso-active agents. Int. J. Radiat. Oncol. Biol. Phys. 16, 1137-1139 (1987).
6. Voorhees, W. D. and Babbs, C. F. Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs. Eur. J. Cancer Clin. Oncol. 19, 1027-1033 (1982).
7. Rowell, N. P., Flower, M.A, McCready, V. R., Cronin, B. and Horwich, A. The effects of single dose hydralazine on blood flow through human lung tumours. Radiother. Oncol. 18, 283-292, (1990).
8. Horsman, M. R., Christensen, K. L. and Overgaard, J. Relationship between hydralazine-induced changes in murine tumour blood supply and mouse blood pressure. Int. J. Radiat. Oncol. Biol. Phys. 22, 455-458 (1992).
9. Horsman, M. R., Nordsmark, M., Høyer, M. and Overgaard, J. Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours. Br. J. Cancer 72, 1474-1478 (1995).
10. Okunieff, P., Kallinowski, F., Vaupel, P. and Neuringer, L. J. Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy. J. Natl. Cancer Inst. 80, 745-750, (1988).
11. Bhujwalla, Z. M., Tozer, G. M., Field, S. B., Maxwell, R. J. and Griffiths, J. R. The energy metabolism of RIF-1 tumours following hydralazine. Radiother. Oncol. 19, 281-291 (1990).
12. 31P magnetic resonance spectroscopy. Int. J. Radiat. Oncol. Biol. Phys. 22, 473-476, (1992).
13. Nordsmark, M., Maxwell, R. J., Wood, P. J., Stratford, I. J., Adams, G. E. and Overgaard, J. Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy. Br. J. Cancer 74, S232-5 (1996).
14. Gillies, R. J., Ogino, T., Shulman, R. G. and Ward, D. C. 31P nuclear magnetic resonance evidence for the regulation of intracellular pH by Ehrlich ascites tumor cells. J. Cell Biol. 95, 24-29, (1982).
15. Warburg, O. The Metabolism of Tumours, Constable, London (1930).
16. 1H-NMR detection of lactate in vivo. Biochim. Biophys. Acta 968, 86-90 (1988).
17. 1H NMR spectroscopy of subcutaneous tumors: preliminary studies of effects of growth, chemotherapy and blood flow reduction. NMR Biomed. 5, 296-302 (1992).
18. Bhujwalla, Z. M., Shungu, D. C. and Glickson, J. D. Effect of blood flow modifiers on tumor metabolism observed in vivo by proton magnetic resonance spectroscopic imaging. Magn. Reson. Med. 36, 204-211 (1996).
19. Bhujwalla, Z. M., Shungu, D. C., He, Q., Wehrle, J. P. and Glickson, J. D., In NMR in Physiology and Biomedicine, R. J. Gillies, Ed. Academic Press, San Diego, CA. 1994, pp. 311-328.
20. Maxwell, R. J., McCoy, C. L. and Horsman, M. R. The measurement of murine tumour pH following hydralazine treatment: the influence of split Pi peaks. 5th Scientific Meeting of the International Society of Magnetic Resonance in Medicine. Abstr., p. 1098 (1997).
21. 2* and resonance frequency weighted magnetic resonance images of rodent tumours. NMR Biomed. 7, 3-11 (1994).
22. Robinson, S. P., Howe, F. A. and Griffiths, J. R. Non invasive monitoring of carbogen-induced changes in tumour blood flow and oxygenation by functional magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 33, 855-859 (1995).
23. Overgaard, J. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. Int. J. Radiat. Oncol. Biol. Phys. 6, 1507-1517 (1980).
24. 1H NMR spectroscopy. J. Magn. Reson. B 104, 1-10 (1994).
25. Green, H. and Freeman, R. Band-selective excitation for multi-dimensional NMR spectroscopy. J. Magn. Reson. 87, 415-421 (1990).
26. Topp, S., Stubgaard, M., Schaumburg, K. and Henriksen, O. Late self-refocusing frequency-selective RF pulses. 12th Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, Abstr., p. 1183 (1993).
27. Schneider, W. G., Bernstein, H. J. and Pople, J. A. Proton mangentic chemical shift of free (gaseous) and associated (liquid) hydride molecules. J. Chem. Phys. 28, 601-607 (1958).
28. De Poorter, J., De Wagter, C., De Deene, Y., Thomsen, C., Ståhlberg, F. and Achten, E. The proton-resonance-frequency-shift method compared with molecular diffusion for quantitative measurement of two-dimensional time-dependent temperature distribution in a phantom. J. Magn. Reson. B 103, 234-241 (1994).
29. Young, I. R., Haijnal, J. V., Oatridge, A., Roberts, I., Wilson, J. A., Saeed, N. and Bydder, G. M. Demonstration of in vivo susceptibility variations developing phase changes that mimic those due to temperature measured by the chemical shift method. 4th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Abstr., p. 44 (1996).
30. Kuroda, K., Suzuki, Y., Ishihara, Y., Okamoto, K. and Suzuki, Y. Temperature mapping using water proton chemical shift obtained with 3D-MRSI: feasibility in vivo. Magn. Reson. Med. 35, 20-29 (1996).
31. 13C resonances. Biochim. Biophys. Acta 805, 104-116 (1984).
32. Bhakoo, K. K., Land, H., Williams, S., Gadian, D. and Noble, M. Phosphorylcholine: a putative marker of cancer. Differential regulation of choline metabolites during oncogenic transformation. Anticancer Res. 15, 1690-1691 (1995).
33. CRC Handbook of Chemistry and Physics, 73rd Edition, D. R. Lide (Ed.), CRC Press, Boca Raton, FL (1993)